Rufu Chen
- Cancer Research top 2%
- Molecular Biology top 10%
- Oncology top 10%
- Surgery
- Immunology
- Topics
- Cancer-related molecular mechanisms research (13 papers)RNA modifications and cancer (7 papers)MicroRNA in disease regulation (6 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Rufu Chen
28 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 84
- Cancer Research 947
- Molecular Biology 942
- Oncology 295
- Surgery 140
- Immunology 132
Countries citing papers authored by Rufu Chen
This map shows the geographic impact of Rufu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rufu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rufu Chen more than expected).
Fields of papers citing papers by Rufu Chen
This network shows the impact of papers produced by Rufu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rufu Chen. The network helps show where Rufu Chen may publish in the future.
Co-authorship network of co-authors of Rufu Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Rufu Chen. A scholar is included among the top collaborators of Rufu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rufu Chen. Rufu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 175 | |
| 3 | 133 | |
| 4 | 50 | |
| 5 | 11 | |
| 6 | 34 | |
| 7 | 10 | |
| 8 | 17 | |
| 9 | 167 | |
| 10 | 15 | |
| 11 | 8 | |
| 12 | 57 | |
| 13 | 100 | |
| 14 | 42 | |
| 15 | 57 | |
| 16 | 33 | |
| 17 | 46 | |
| 18 | 19 | |
| 19 | 11 | |
| 20 | Inhibition of VEGF expression by antisense oligodeoxynucleotides in cholangiocarcinoma | 1 |
About Rufu Chen
Rufu Chen is a scholar working on Cancer Research, Transplantation and Oncology, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (13 papers), RNA modifications and cancer (7 papers) and MicroRNA in disease regulation (6 papers). The work is most often cited by research in Cancer Research (947 citations), Molecular Biology (942 citations) and Oncology (295 citations). Rufu Chen has collaborated with scholars based in China and United States. Frequent co-authors include Huilin Ye, Quanbo Zhou, Shangyou Zheng, Zhiqiang Fu, Qing Lin, Xiaohui Zhao, Yimin Liu, Guolin Li, Jiajia Zhou and Zhihua Li. Their work appears in journals such as PLoS ONE, International Journal of Cancer and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.